Shayla Sharmin
Family · Sugar Land, TXNPI 1104460070
Payments from drug & device makers
Across 125 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$477
- Lilly USA, LLC$468
- Novo Nordisk$350
- Merck$165
- Amgen$165
- Bayer$121
- plus $745 from 16 others
What the payments were for
- Food & beverage$2,47499%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $477 |
| Lilly USA, LLC | 17 | $468 |
| Novo Nordisk | 18 | $350 |
| Merck | 8 | $165 |
| Amgen | 9 | $165 |
| Bayer | 6 | $121 |
| Boehringer Ingelheim | 5 | $95 |
| Astellas Pharma US Inc | 4 | $85 |
| AstraZeneca | 5 | $84 |
| Pfizer | 5 | $82 |
| Kowa Pharmaceuticals America, Inc. | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Nestle Healthcare Nutrition Inc. | 2 | $25 |
| Lundbeck LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novartis | 1 | $23 |
| Exact Sciences | 1 | $21 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$114
How this compares
$2,491 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 72 | $86,159 |
| OzempicSemaglutide | 70 | $83,622 |
| JanuviaSitagliptin Phosphate | 43 | $51,964 |
| JardianceEmpagliflozin | 47 | $46,994 |
| EliquisApixaban | 15 | $22,634 |
| RybelsusSemaglutide | 12 | $11,465 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $10,574 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $6,185 |
| VascepaIcosapent Ethyl | 16 | $3,915 |
| Rosuvastatin Calcium | 126 | $2,762 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,272 |
| Fluocinonide | 12 | $2,049 |
| Potassium Chloride | 54 | $1,803 |
| Silver Sulfadiazine | 20 | $1,579 |
| Celecoxib | 13 | $1,443 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $350 | $95,08782 claims |
| Lilly USA, LLCMounjaro | $468 | $86,15972 claims |
| MerckJanuvia | $165 | $51,96443 claims |
| Boehringer IngelheimJardiance | $95 | $46,99447 claims |
| PfizerEliquis | $82 | $22,63415 claims |
| GSKTrelegy Ellipta | $16 | $10,57415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.
Other family in Sugar Land
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.